VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ELCC 2021 | Targeting RET in lung cancer

Federico Cappuzzo, MD, PhD, AUSL della Romagna, Ravenna, Italy, outlines therapeutic options for the treatment of patients with RET-positive lung cancer, highlighting the use of selpercatinib and pralsetinib in advanced disease. Dr Cappuzzo also discusses the importance of screening patients for RET rearrangements. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter